Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haleem Pharmaceuticals is an Egyptian pharmaceutical company headquartered in Badr City, Cairo, specializing in the development and manufacturing of generic medicines. The company focuses on providing high-quality, affordable therapeutic solutions across several key areas, including gastroenterology, cardiology, and infectious diseases. Haleem Pharma operates a modern manufacturing facility that complies with international Good Manufacturing Practice (GMP) standards, producing various oral dosage forms. Their portfolio includes well-known generic versions of essential drugs, serving both the domestic Egyptian market and expanding into regional markets in the Middle East and Africa. By emphasizing quality control and accessible pricing, the company aims to improve patient outcomes in its target regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haleem Pharma.